Literature DB >> 24524760

Peptide-based nanostructures for cancer diagnosis and therapy.

Linna An, M Rehan H Shah Gilani, Gaolin Liang1.   

Abstract

Peptide-based nanoparticles (pep-NPs) are emerging as promising imaging and therapeutic agents against cancer due to their biocompatibility and tunability. Optimized design of the peptide sequence and moderate conjugation of the sequence with extraneous molecules are crucial to the performance of the inherent properties of pep-NPs such as nanostructure formation and ability of drug delivery. Meanwhile, the peptide sequences based on natural/unnatural amino acids could be utilized for designing nanostructures susceptive/resistant to specific enzymes. Herein, we firstly summarize the basic peptide structures to provide a whole image of pep-NPs. Subsequently, the diagnostic strategies based on different imaging modalities and recent therapeutic applications of pep-NPs for cancer are reviewed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24524760     DOI: 10.2174/0929867321666140205140600

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

Review 1.  Peptide-based imaging agents for cancer detection.

Authors:  Xiaolian Sun; Yesen Li; Ting Liu; Zijing Li; Xianzhong Zhang; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2016-06-18       Impact factor: 15.470

2.  High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.

Authors:  Xinxin Yu; Renshu Zhang; Lei Lei; Qianqian Song; Xingyi Li
Journal:  Int J Nanomedicine       Date:  2019-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.